全文获取类型
收费全文 | 1441篇 |
免费 | 136篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 23篇 |
妇产科学 | 15篇 |
基础医学 | 110篇 |
口腔科学 | 50篇 |
临床医学 | 141篇 |
内科学 | 160篇 |
皮肤病学 | 20篇 |
神经病学 | 35篇 |
特种医学 | 79篇 |
外科学 | 231篇 |
综合类 | 332篇 |
预防医学 | 115篇 |
眼科学 | 5篇 |
药学 | 129篇 |
2篇 | |
中国医学 | 75篇 |
肿瘤学 | 103篇 |
出版年
2024年 | 8篇 |
2023年 | 8篇 |
2022年 | 38篇 |
2021年 | 47篇 |
2020年 | 37篇 |
2019年 | 20篇 |
2018年 | 25篇 |
2017年 | 40篇 |
2016年 | 27篇 |
2015年 | 79篇 |
2014年 | 59篇 |
2013年 | 95篇 |
2012年 | 130篇 |
2011年 | 138篇 |
2010年 | 107篇 |
2009年 | 97篇 |
2008年 | 82篇 |
2007年 | 73篇 |
2006年 | 78篇 |
2005年 | 78篇 |
2004年 | 40篇 |
2003年 | 42篇 |
2002年 | 40篇 |
2001年 | 21篇 |
2000年 | 19篇 |
1999年 | 22篇 |
1998年 | 22篇 |
1997年 | 17篇 |
1996年 | 15篇 |
1995年 | 12篇 |
1994年 | 7篇 |
1993年 | 16篇 |
1992年 | 5篇 |
1990年 | 3篇 |
1989年 | 9篇 |
1988年 | 6篇 |
1987年 | 8篇 |
1986年 | 10篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1975年 | 3篇 |
1973年 | 2篇 |
1969年 | 2篇 |
排序方式: 共有1633条查询结果,搜索用时 15 毫秒
61.
We describe a case of 64-year-old female patient with ventricular tachycardia intractable to medical treatment and acute heart failure following myocardial infarction. Emergency surgical ventricular reconstruction and subendocardial resection was undertaken. We discuss the option of surgical intervention in this difficult and unusual clinical scenario. 相似文献
62.
63.
64.
目的:探讨美托洛尔缓释片治疗原发性高血压(EH)并舒张压性心力衰竭(DHF)患者的临床疗效。方法:选取2010年7月-2013年4月本院就诊的126例EH合并DHF患者作为研究对象,所有患者给予美托洛尔缓释片治疗12个月。分别观察治疗前后患者的血压、心率、VEGF和hs-CRP水平的变化,同时观察心脏结构、左室功能参数变化及心功能分级的变化情况。结果:治疗后,左室舒张末径(LVEDD)和左室收缩末径(LVESD)显著减小,二尖瓣返流现象显著减轻,左室射血分数(LVEF)、左室高峰充盈数(LVPFR)显著增加,收缩压、舒张压、脉压和心率以及VEGF和hs-CRP、N末端钠肽原(NT-proBNP)均显著降低,上述指标治疗前后比较差异均具有统计学意义(P<0.05)。结论:美托洛尔缓释片治疗EH并DHF患者,能显著改善患者的心脏功能,治疗效果显著,值得在临床上进一步推广。 相似文献
65.
目的 调查成人阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者的人格特征及生活质量,了解该患病群体的心理健康情况。方法 采用明尼苏达多项人格测量表(Minnesota multiphasic personality inventory,MMPI)和简明健康状况调查表(the MOS item short from health survey,SF-36)分别对98例成人OSAHS患者及100例单纯鼾症志愿者进行问卷调查,评价OSAHS患者的人格特征及生活质量情况并进行对照性研究。结果 在MMPI调查中,OSAHS患者在抑郁、疑病、精神衰弱、情绪不稳定、精神分裂临床量表T分高于单纯鼾症组,差异具有统计学意义(P<0.05),其中OSAHS组中女性患者的抑郁、疑病、精神衰弱、情绪不稳定、精神分裂、社会内向临床量表T分高于男性患者,差异具有统计学意义(P <0.05)。在SF-36调查中,OSAHS患者在生理职能、一般健康状况、躯体疼痛、精力、社会功能、情感功能、精神健康7个维度的平均评分低于单纯鼾症组,差异具有统计学意义(P<0.05)。结论 OSAHS患者有较多的心理健康问题,表现更多的易疲劳、注意缺陷,生活质量更低,OSAHS病情越重,心理健康问题越大,女性患者尤重。 相似文献
66.
Matteo Lambertini Francesca Poggio Marco Bruzzone Benedetta Conte Claudia Bighin Evandro de Azambuja Mario Giuliano Michele De Laurentiis Francesco Cognetti Alessandra Fabi Giancarlo Bisagni Antonio Durando Anna Turletti Ylenia Urracci Ornella Garrone Fabio Puglisi Filippo Montemurro Marcello Ceppi Lucia Del Mastro the GIM investigators 《International journal of cancer. Journal international du cancer》2020,147(1):160-169
Dose-dense adjuvant chemotherapy is standard of care in high-risk early breast cancer patients. However, its role in HER2-positive patients is still uncertain. In this exploratory analysis of the GIM2 trial, we investigated the efficacy of dose-dense chemotherapy in HER2-positive breast cancer patients with or without exposure to trastuzumab. In the GIM2 trial, node-positive early breast cancer patients were randomized to receive four cycles of (fluorouracil)epirubicin/cyclophosphamide followed by four cycles of paclitaxel administered every 2 (dose-dense) or 3 (standard-interval) weeks. After approval of adjuvant trastuzumab, protocol was amended in April 2006 to allow use of trastuzumab for 1 year after chemotherapy completion in HER2-positive patients. The efficacy of dose-dense chemotherapy in terms of disease-free survival (DFS) and overall survival (OS) was assessed according to HER2 status and trastuzumab use. Out of 2,003 breast cancer patients, HER2 status was negative/unknown in 1,551 patients; among the 452 patients with HER2-positive breast cancer, chemotherapy alone or followed by trastuzumab was given to 320 and 132 patients, respectively. Median follow-up was 8.1 years. No significant interaction between HER2 status, trastuzumab use and chemotherapy treatment was observed for both DFS (p = 0.698) and OS (p = 0.708). Nevertheless, there was no apparent benefit in the HER2-positive group treated with trastuzumab (DFS: HR, 0.99; 95% CI 0.52–1.89; OS: HR, 0.95; 95% CI 0.37–2.41). Although dose-dense chemotherapy was associated with a significant survival improvement in high-risk breast cancer patients, its benefit appeared to be smaller (if any) in patients with HER2-positive disease who received adjuvant trastuzumab. 相似文献
67.
68.
目的 通过对不同便携式血糖仪与贝克曼库尔特A U 5800全自动生化分析仪(A U 5800)检测血糖结果的一致性比对和抗干扰能力的研究,为临床选择适合的血糖仪提供参考.方法 共选取4种不同检测原理的2台进口(A和B)和2台国产(C和D)血糖仪,与A U 5800同时检测不同浓度的血糖并进行比较,分析其一致性.分别检测... 相似文献
69.
牙周炎是口腔常见病、多发病,是牙齿松动的主要原因之一.牙周夹板一直以来是松牙固定的有效手段,它可以将多个牙连成一个整体,形成一个“多根巨牙”,共同承担咬合力,有效地分散牙周膜及牙槽骨的应力,为牙周组织的愈合创造有利条件.三维有限元分析法是研究复杂模型应力分布的生物力学方法,近年来广泛应用于牙周夹板的研究中,该方法可以逼... 相似文献
70.
B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells 总被引:8,自引:1,他引:8
Uckun FM; Fauci AS; Heerema NA; Song CW; Mehta SR; Gajl-Peczalska K; Chandan M; Ambrus JL 《Blood》1987,70(4):1020-1034
The purpose of this study was to analyze the expression of B cell growth factor (BCGF) receptors and to elucidate the biologic effects of biochemically purified natural BCGF at the B cell precursor stage of human B lineage lymphoid differentiation. The specific binding of radioiodinated high-mol-wt BCGF (125I-HMW-BCGF) and low-molecular-wt BCGF (125I-LMW-BCGF) to fresh marrow blasts from B cell precursor acute lymphoblastic leukemia (ALL) patients was initially investigated. The estimated number of radioiodinated BCGF molecules bound per blast ranged from undetectable to 24.3 X 10(3) for HMW-BCGF, and from 11.5 X 10(3) to 457.8 X 10(3) for LMW-BCGF. In 3H-TdR incorporation assays, 75% of cases showed a significant response to LMW-BCGF with a median stimulation index of 9.3. By comparison, only 33% of cases showed a significant response to HMW-BCGF with a median stimulation index of 2.4. Subsequently, B cell precursor colony assays were performed to assess and compare the biologic effects of BCGF on leukemic B lineage lymphoid progenitor cells. Among 28 cases studied, 57% responded to both HMW-BCGF and LMW-BCGF, 21% responded only to LMW-BCGF, and the remaining cases showed no proliferative response to either growth factor. The response patterns of virtually pure populations of FACS- sorted leukemic B cell precursors were essentially identical to the proliferative responses of unsorted leukemic B-cell precursors. Synergistic effects between HMW-BCGF and LMW-BCGF were observed in 80% of the cases that responded to both. The numbers of cell-bound radioiodinated BCGF molecules, the stimulation indices, as well as the number of B cell precursor colonies in BCGF-stimulated cultures showed a marked interpatient variation. Patients with structural chromosomal abnormalities (SCAs) involving 12p11-13 or patients with a Philadelphia chromosome showed a greater HMW-BCGF response at the level of leukemic progenitor cells than did other patients (P = .02). The LMW-BCGF response was significantly greater for patients with SCA than for patients without SCA (P = .04). The response of leukemic progenitor cells to HMW-BCGF or LMW-BCGF did not correlate with sex, age, disease status, FAB morphology, WBC at diagnosis, or immunophenotype. To our knowledge, this study represents the first detailed analyses of BCGF receptor expression and BCGF effects in B cell precursor ALL. The data presented provide direct evidence for the expression of functional receptors for both HMW-BCGF and LMW-BCGF in B cell precursor ALL. 相似文献